Proton Pump Inhibitors

PPIs don't just block acid — they irreversibly disable the pump that makes it. That's why they outperform H2 blockers, but it's also why long-term risks accumulate in ways students rarely anticipate.

Proton pump inhibitors (omeprazole, pantoprazole, esomeprazole, lansoprazole) irreversibly bind and inactivate the hydrogen-potassium ATPase pump on gastric parietal cells — the final step of acid secretion. Because the block is irreversible, acid suppression lasts 24 hours even though the drug's plasma half-life is short; the body must synthesize new pumps to resume secretion. This makes PPIs the most potent acid suppressors available. Indications include GERD, erosive esophagitis, Zollinger-Ellison syndrome, peptic ulcer disease, and as part of H. pylori triple therapy (PPI + clarithromycin + amoxicillin). PPIs should be taken 30–60 minutes before the first meal of the day because the pumps must be actively secreting acid to be vulnerable to the drug. IV pantoprazole is used for acute GI bleeds when the client is NPO. Short-term use is generally safe, but long-term use (>1 year) carries risks: decreased calcium and magnesium absorption increases fracture risk and hypomagnesemia, reduced B12 absorption, and increased susceptibility to C. difficile infection due to loss of the gastric acid barrier. Monitor magnesium levels in clients on prolonged therapy.

Key Distinctions

Don't confuse PPIs with H2 blockers: PPIs irreversibly block the proton pump (final pathway), while H2 blockers reversibly block histamine receptors (one of several acid-stimulating pathways) — PPIs are stronger and longer-acting. Students often think PPIs work immediately; full therapeutic effect for GERD takes 1–2 weeks of daily dosing. Taking a PPI at bedtime instead of before breakfast significantly reduces its effectiveness.

Clinical Pearl

Thirty minutes before breakfast, on an empty stomach — if the pump isn't working, the drug can't kill it. Timing is the therapy.